会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 4. 发明申请
    • Substituted Rylene Derivatives
    • 取代的Rylene衍生物
    • US20080167467A1
    • 2008-07-10
    • US11994719
    • 2006-07-06
    • Martin KonemannArno BohmNeil Gregory PschirerJianqiang QuGabriele Mattern
    • Martin KonemannArno BohmNeil Gregory PschirerJianqiang QuGabriele Mattern
    • C07D221/18
    • C07D493/06C07D471/06C08K5/0041C08K5/3437
    • Rylene derivatives of the general formula I in which the variables are each defined as follows: Rylene is a polycyclic conjugated ring system which comprises at least one perylene unit may comprise heteroatoms as ring atoms, may be functionalized by moieties comprising —CO— groups and/or may bear further substituents other than the A radicals; A is a radical of the formula X is oxygen or sulfur; R are identical or different radicals: optionally substituted alkyl, cycloalkyl, aryl, hetaryl, —U-aryl where U is an —O—, —S—, —NR2—, —CO—, —SO— or —SO2— moiety, or C1-C12-alkoxy, C1-C6-alkylthio, —C≡CR2, —CR2═CR22, hydroxy, mercapto, halogen, cyano, nitro, —NR3R4, —NR3COR4, —CONR3R4, —SO2NR3R4, —COOR3 or —SO3R3; R′ are identical or different radicals: hydrogen or one of the R radicals; R2 is hydrogen or alkyl, where the R2 radicals may be the same or different when they occur more than once; R3, R4 are each independently hydrogen; optionally substituted alkyl, aryl or hetaryl; n is from 1 to 8.
    • 通式I的亚芳基衍生物各自定义如下:Rylene是多环共轭环系,其包含至少一个苝单元可以包含杂原子作为环原子,可以由包含-CO-基团和/ 或者可以承担除了A基团之外的其它取代基; A是式X的基团是氧或硫; R是相同或不同的基团:任选取代的烷基,环烷基,芳基,杂芳基,-U-芳基,其中U是-O - , - S - , - NR 2 - , - CO-, - SO - 或-SO 2 - 部分,或C 1 -C 12 - 烷氧基,C 1 -C -C≡CR2,-CR 2 -CR 2,2 - , - 羟基,巯基,卤素,氰基,硝基,-NR 3,R 4,-NR 3,COR 4, SO 2,SO 2,SO 2,SO 2,SO 3,SO 4,SO 2, >,-COOR 3或-SO 3 R 3; R'是相同或不同的基团:氢或R基团之一; R 2是氢或烷基,其中R 2个基团当它们不止一次出现时可以相同或不同; R 3,R 4各自独立地为氢; 任选取代的烷基,芳基或杂芳基; n为1至8。
    • 8. 发明授权
    • Substituted quaterrylene tetracarboxylic acid diimides
    • 取代的四亚甲基四羧酸二酰亚胺
    • US6124458A
    • 2000-09-26
    • US335535
    • 1999-06-18
    • Klaus MuellenHeribert QuanteArno Bohm
    • Klaus MuellenHeribert QuanteArno Bohm
    • C07D221/18C07D471/06C09B5/62C09B57/08
    • C07D221/18C09B5/62
    • Quaterrylenetetracarboxylic diimides I whereR is hydrogen;C.sub.1 -C.sub.30 -alkyl whose carbon chain may be interrupted by one or more of --O--, --S--, --NR.sup.1 --, --CO-- and/or --SO.sub.2 -- and which may be monosubstituted or polysubstituted by cyano, C.sub.1 -C.sub.6 -alkoxy or a 5-, 6- or 7-membered heterocyclic radical which is attached via a nitrogen atom and which may contain further heteroatoms and may be aromatic, whereR.sup.1 is hydrogen or C.sub.1 -C.sub.6 -alkyl;C.sub.5 -C.sub.8 -cycloalkyl whose carbon skeleton may be interrupted by one or more of --O--, --S-- and/or --NR.sup.1 --;aryl or hetaryl, which may each be monosubstituted or poly-substituted by C.sub.1 -C.sub.18 -alkyl, C.sub.1 -C.sub.6 -alkoxy, cyano, --CONHR.sup.2, --NHCOR.sup.2 and/or aryl- or hetaryl-azo, which may each be substituted by C.sub.1 -C.sub.10 -alkyl, C.sub.1 -C.sub.6 -alkoxy or cyano, whereR.sup.2 is hydrogen; C.sub.1 -C.sub.18 -alkyl; aryl or hetaryl, which may each be substituted by C.sub.1 -C.sub.6 -alkyl, C.sub.1 -C.sub.6 -alkoxy, halogen or cyano;X is halogen; C.sub.1 -C.sub.18 -alkyl; aryloxy, arylthio, hetaryloxy or hetarylthio, which may each be substituted by C.sub.1 -C.sub.4 -alkyl or C.sub.1 -C.sub.4 -alkoxy;n is from 2 to 12,their preparation and use as pigments or fluorescent dyes and also substituted 9-haloperylene-3,4-dicarbimides III as intermediates therefor.
    • 四芳基四羧酸二酰亚胺I,其中R是氢; 其碳链可以被-O - , - S - , - NR 1 - , - CO - 和/或-SO 2 - 中的一个或多个中断的C 1 -C 30 - 烷基,并且其可以被氰基,C 1 -C 6单取代或多取代 - 烷氧基或5-,6-或7-元杂环基,其通过氮原子连接并且可以含有另外的杂原子并且可以是芳族的,其中R 1是氢或C 1 -C 6 - 烷基; 碳骨架可被-O - , - S-和/或-NR1-中的一个或多个中断的C 5 -C 8 - 环烷基; 芳基或杂芳基,其可以各自被C1-C18-烷基,C1-C6-烷氧基,氰基,-CONHR2,-NHCOR2和/或芳基 - 或杂芳基 - 偶氮基单取代或多取代,其可以各自被C1 -C 10 - 烷基,C 1 -C 6 - 烷氧基或氰基,其中R 2是氢; C1-C18-烷基; 芳基或杂芳基,其各自可被C 1 -C 6 - 烷基,C 1 -C 6 - 烷氧基,卤素或氰基取代; X是卤素; C1-C18-烷基; 芳氧基,芳硫基,杂芳氧基或杂芳硫基,其各自可被C 1 -C 4 - 烷基或C 1 -C 4 - 烷氧基取代; n为2至12,它们的制备和用作颜料或荧光染料,并且还取代了9-卤代亚烷基-3,4-二酰亚胺III作为其中间体。
    • 9. 发明申请
    • METHOD FOR CONVERTING PERYLEN-3,4:9,10-TETRACARBOXYLIC ACID DIIMIDES INTO A FORM SUITABLE FOR USE AS A FLUORESCENT DYE
    • 将季戊四烯-3,4:9,10-四羧酸二异氰酸酯转化为适用于荧光染料的形式的方法
    • US20090176985A1
    • 2009-07-09
    • US12346262
    • 2008-12-30
    • Peter ERKSimone SchaeferArno BohmPeter BlaschkaHarald ArmsWilli Helfer
    • Peter ERKSimone SchaeferArno BohmPeter BlaschkaHarald ArmsWilli Helfer
    • C07D471/06
    • C09B67/0014C09B67/0025
    • A process for converting perylene-3,4:9,10-tetracarboximides of the general formula I in which R1 and R2 are each unbranched, branched or cyclic C1-C8-alkyl to a form suitable for use as fluorescent dyes, which comprises a) dissolving or suspending the perylene-3,4:9,10-tetracarboximides whose molecules have a molecular volume of ≦230 Å3 in an organic or inorganic solvent at from 0 to 250° C., b1) cooling the solution obtained in step a) to or below the crystallization temperature and, in the case of an organic solvent, if desired at the same time removing excess solvent until the first crystals form, or, in the case of an inorganic solvent, adding water or dilute aqueous solutions of the solvent until the first crystals form, and maintaining the solution at this temperature for further crystallization or b2) cooling the suspension obtained in step a) to or below the crystallization temperature when the temperature in step a) was above the crystallization temperature, and maintaining the suspension at this temperature for further crystallization, c) isolating the solvate crystals formed in step b) and d) then removing the solvent from the solvate crystals, and also novel crystalline forms of perylene-3,4:9,10-tetracarboxylic diimides.
    • 用于将通式I的苝-3,4:9,10-四甲酰亚胺转化为其中R 1和R 2各自是非支链,支链或环状的C 1 -C 8烷基的方法,其适于用作荧光染料,其包含 )在0-250℃下将分子体积分数为<= 230的二萘嵌苯-3,4:9,10-四甲酰亚胺溶解或悬浮在有机或无机溶剂中,b1)冷却步骤 a)达到或低于结晶温度,并且在有机溶剂的情况下,如果需要,同时除去过量的溶剂直到形成第一晶体,或者在无机溶剂的情况下,加入水或稀的水溶液 溶剂直至形成第一晶体,并将溶液保持在该温度下进一步结晶,或b)当步骤a)中的温度高于结晶温度时,将步骤a)中获得的悬浮液冷却至或低于结晶温度,并维持 g在该温度下的悬浮液进一步结晶,c)分离步骤b)中形成的溶剂合物晶体,d)然后从溶剂合物晶体中除去溶剂,以及新型的苝-3,4:9,10-四羧酸的结晶形式 二酰亚胺